Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where B. Ceglarek is active.

Publication


Featured researches published by B. Ceglarek.


Acta haematologica Polonica | 2013

Nabyta choroba von Willebranda (AVWS) przyczyną skazy krwotocznej u chorej z wywiadem niedoczynności tarczycy i niewydolnością nerek

K. Bykowska; Anna Sikorska; B. Ceglarek; Bożena Sokołowska; B. Baran; Jerzy Windyga

B. Baran *, E. Odnoczko , E. Stefanska-Windyga , K. Bykowska , J. Oldenburg , J. Windyga 1 Zaklad Hemostazy i Chorob Metabolicznych, Instytut Hematologii i Transfuzjologii, Warszawa, Polska Poradnia Zaburzen Hemostazy, Instytut Hematologii i Transfuzjologii, Warszawa, Polska 3 Instytut Hematologii Eksperymentalnej i Transfuzjologii, Bonn, Niemcy *Autor prezentujący i do korespondencji. Adres email: [email protected]


Blood | 2000

Cladribine with prednisone versus chlorambucil with prednisone as first-line therapy in chronic lymphocytic leukemia: report of a prospective, randomized, multicenter trial

Tadeusz Robak; Jerzy Z. Blonski; Marek Kasznicki; Maria Blasinska-Morawiec; Euzebiusz Krykowski; Anna Dmoszynska; Halina Mrugala-Spiewak; Aleksander B. Skotnicki; Wieslaw Nowak; Lech Konopka; B. Ceglarek; Stanisław Maj; Jadwiga Dwilewicz-Trojaczek; Andrzej Hellmann; Ignacy Urasinski; Barbara Zdziarska; Sabina Kotlarek-Haus; Stanislaw Potoczek; Paweł Grieb


Blood | 2009

Impact of Prior Therapy and Suboptimal Response to Imatinib On the Efficacy and Safety of Nilotinib Among 1,422 Patients with Imatinib-Resistant or —Intolerant Chronic Myeloid Leukemia (CML) in Chronic Phase (CP): Sub-Analyses of the ENACT (Expanding Nilotinib Access in Clinical Trials) Study.

Franck E. Nicolini; Dong-Wook Kim; B. Ceglarek; Anna G. Turkina; Giuliana Alimena; Haifa Kathrin Al-Ali; Zhixiang Shen; Graeme N. Smith; Carmino Antonio de Souza; Pedro Enrique Dorlhiac-Llacer; David A. Rizzieri; Tomasz Szczudlo; Myriam Berton; Jim Wang; Christine Bieri; Philipp le Coutre


Blood | 2009

Efficacy and Safety of Nilotinib in Elderly Patients with Imatinib-Resistant or -;Intolerant Chronic Myeloid Leukemia (CML) in Chronic Phase (CP): A Sub-Analysis of the ENACT (Expanding Nilotinib Access in Clinical Trials) Study.

Philipp le Coutre; Anna G. Turkina; Dong-Wook Kim; B. Ceglarek; Giuliana Alimena; Haifa Kathrin Al-Ali; Zhixiang Shen; Graeme N. Smith; Carmino Antonio de Souza; Pedro Enrique Dorlhiac-Llacer; David A. Rizzieri; Tomasz Szczudlo; Myriam Berton; Jim Wang; Si-Tien Wang; Franck E. Nicolini


Blood | 2009

Patterns and Management of Selected Adverse Events of Adult Patients with Imatinib-Resistant or -Intolerant Chronic Myeloid Leukemia (CML) From the ENACT (Expanding Nilotinib Access in Clinical Trials) Study.

Philipp le Coutre; B. Ceglarek; Anna G. Turkina; Dong-Wook Kim; Giuliana Alimena; Haifa Kathrin Al-Ali; Zhixiang Shen; Graeme N. Smith; Carmino Antonio de Souza; David A. Rizzieri; Tomasz Szczudlo; Myriam Berton; Jim Wang; Ellison Dial; Franck E. Nicolini


Blood | 2004

Cladribine Alone or in Combination with Cyclophosphamide or Cyclophosphamide and Mitoxantrone as First Line Treatment in Chronic Lymphocytic Leukemia: An Early Report of Prospective Randomized Study.

Tadeusz Robak; Jerzy Z. Blonski; Joanna Gora-Tybor; Marek Kasznicki; Jadwiga Dwilewicz-Trojaczek; Agnieszka Tomaszewska; Lech Konopka; B. Ceglarek; Janusz Kloczko; Jaroslaw Sokolowski; Anna Dmoszynska; Malgorzata Kowal; Krystyna Zawilska; Beata Stella-Holowiecka; Kazimierz Sulek; Krzysztof Warzocha; Malgorzata Calbecka; Aleksander B. Skotnicki


Blood | 2005

Randomized Comparison of Cladribine with Cyclophosphamide and Fludarabine with Cyclophosphamide in Previously Untreated Progressive and Symptomatic Chronic Lymphocytic Leukemia: The Interim Analysis of PALG CLL3 Trial.

Tadeusz Robak; Jerzy Z. Blonski; Joanna Gora-Tybor; Jacek Najda; Beata Stella-Holowiecka; Malgorzata Calbecka; Malgorzata Kowal; Anna Dmoszynska; B. Ceglarek; Lech Konopka; Tomasz Szpila; Krzysztof Warzocha; Jaroslaw Piszcz; Janusz Kloczko; Krystyna Zawilska; Andrzej Mital; Andrzej Hellmann; Stanislaw Potoczek; Kazimierz Sulek; Andrzej Zdunczyk; Marek Kasznicki


Blood | 2008

Randomized Comparison of Cladribine Plus Cyclophosphamide with Fludarabine Plus Cyclophosphamde in Untreated Patients with Chronic Lymphocytic Leukemia: Report of the Polish Adult Leukemia Group (PALG-CLL3).

Tadeusz Robak; Jerzy Z. Blonski; Krzysztof Jamroziak; Joanna Gora-Tybor; Beata Stella-Holowiecka; Lech Konopka; B. Ceglarek; Krzysztof Warzocha; Ilona Seferynska; Janusz Kloczko; Jaroslaw Piszcz; Malgorzata Calbecka; Aleksandra Kostyra; Jadwiga Dwilewicz-Trojaczek; Elżbieta Wiater; Anna Dmoszynska; Malgorzata Kowal; Krystyna Zawilska; Alina Grzywacz; Andrzej Hellmann; Andrzej Mital; Andrzej Zdunczyk; Jacek Dybowicz; Stanislaw Potoczek; Aleksander B. Skotnicki; Maria Nowakowska-Domagala; Krzysztof Lewandowski; Kazimierz Sulek


Journal of Transfusion Medicine | 2017

Otyłość u chorego na hemofilię — opis przypadku

Anna Sikorska; Alicja Elżbieta Woźniak; Agata Lewandowska; B. Ceglarek; Elżbieta Tatarska; Jerzy Windyga


Acta haematologica Polonica | 2015

The Acquired Deficiency of Factors II, VII, IX, and X in the Course of the Intoxication of Second Generation Anticoagulant Rodenticides in Female Patient Suffering from Severe Diathesis Haemorrhagica – a case report

B. Ceglarek; K. Bykowska; Anna Sikorska; B. Baran; Adam Wiszniewski; Jerzy Windyga

Collaboration


Dive into the B. Ceglarek's collaboration.

Top Co-Authors

Avatar

Lech Konopka

Medical University of Łódź

View shared research outputs
Top Co-Authors

Avatar

Anna Dmoszynska

Medical University of Lublin

View shared research outputs
Top Co-Authors

Avatar

Jerzy Z. Blonski

Medical University of Łódź

View shared research outputs
Top Co-Authors

Avatar

Krzysztof Warzocha

Medical University of Łódź

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Kazimierz Sulek

Medical University of Łódź

View shared research outputs
Top Co-Authors

Avatar

Marek Kasznicki

Medical University of Łódź

View shared research outputs
Top Co-Authors

Avatar

Tadeusz Robak

Medical University of Łódź

View shared research outputs
Top Co-Authors

Avatar

Andrzej Hellmann

Medical University of Łódź

View shared research outputs
Researchain Logo
Decentralizing Knowledge